Common Cold News and Research

RSS
What do we know about the origin and evolution of SARS-CoV-2?

What do we know about the origin and evolution of SARS-CoV-2?

Researchers explain how online symptom checkers generate probable diagnoses and suggestions

Researchers explain how online symptom checkers generate probable diagnoses and suggestions

Children develop strong, long-lasting immunity following SARS-CoV-2 infection

Children develop strong, long-lasting immunity following SARS-CoV-2 infection

New COVID-19 vaccine could provide protection against existing and future strains of coronaviruses

New COVID-19 vaccine could provide protection against existing and future strains of coronaviruses

New nanoparticle SARS-CoV-2 vaccine confers robust protection with single dose after two weeks

New nanoparticle SARS-CoV-2 vaccine confers robust protection with single dose after two weeks

Study discovers new target on SARS-CoV-2 spike for protective antibodies

Study discovers new target on SARS-CoV-2 spike for protective antibodies

Study: COVID-19 vaccines may remain effective against new influenza viruses

Study: COVID-19 vaccines may remain effective against new influenza viruses

FDA approves new indication for drug to treat pediatric NDO patients

FDA approves new indication for drug to treat pediatric NDO patients

Three commonly used antiviral drugs potentially effective at preventing replication of SARS-CoV-2

Three commonly used antiviral drugs potentially effective at preventing replication of SARS-CoV-2

Research identifies ways to prevent coronavirus spread to the nervous system

Research identifies ways to prevent coronavirus spread to the nervous system

COVID-19 prevention strategies may have led to a decrease in common respiratory infections

COVID-19 prevention strategies may have led to a decrease in common respiratory infections

AstraZeneca's COVID-19 vaccine protects against symptomatic disease

AstraZeneca's COVID-19 vaccine protects against symptomatic disease

Engineering immunogens to focus immune response to SARS-CoV-2

Engineering immunogens to focus immune response to SARS-CoV-2

Can vaccination and infection rates add up to reach Covid herd immunity?

Can vaccination and infection rates add up to reach Covid herd immunity?

Genome-wide CRISPR screening used to identify factors essential for SARS-CoV-2 infection in humans

Genome-wide CRISPR screening used to identify factors essential for SARS-CoV-2 infection in humans

SARS-CoV-2 is extremely sensitive to type I IFN pre-treatment, study finds

SARS-CoV-2 is extremely sensitive to type I IFN pre-treatment, study finds

How likely is SARS-CoV-2 reinfection?

How likely is SARS-CoV-2 reinfection?

Graphene oxide-silver nanoparticles shown to rapidly neutralize RNA viruses

Graphene oxide-silver nanoparticles shown to rapidly neutralize RNA viruses

Antibody and T cell response to SARS-CoV-2 persist up to 8 months: Study of Ski Resort Ischgl

Antibody and T cell response to SARS-CoV-2 persist up to 8 months: Study of Ski Resort Ischgl

What makes viruses infectious?

What makes viruses infectious?